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Background: We had previously shown that the bLZip domain-containing transcription factor, Zhangfei/CREBZF
inhibits the growth and the unfolded protein response (UPR) in cells of the D–17 canine osteosarcoma (OS) line
and that the effects of Zhangfei are mediated by it stabilizing the tumour suppressor protein p53. To determine if
our observations with D-17 cells applied more universally to canine OS, we examined three other independently
isolated canine OS cell lines—Abrams, McKinley and Gracie.
Results: Like D–17, the three cell lines expressed p53 proteins that were capable of activating promoters with p53
response elements on their own, and synergistically with Zhangfei. Furthermore, as with D–17 cells, Zhangfei
suppressed the growth and UPR-related transcripts in the OS cell lines. Zhangfei also induced the activation of
osteocalcin expression, a marker of osteoblast differentiation and triggered programmed cell death.
Conclusions: Osteosarcomas are common malignancies in large breeds of dogs. Although there has been dramatic
progress in their treatment, these therapies often fail, leading to recurrence of the tumour and metastatic spread.
Our results indicate that induction of the expression of Zhangfei in OS, where p53 is functional, may be an effective
modality for the treatment of OS.
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Osteosarcoma (OS) is the most common primary malig-
nant bone tumour in children and adolescents, although
its incidence in dogs is ten times greater than in humans
[1]. Spontaneously occurring osteosarcomas in dogs are
an ideal model for cancer research due to their anatom-
ical and physiological similarities with human counter-
parts (reviewed by [2-4]).
We had previously shown that the basic leucine zipper
(bLZip) domain-containing transcription factor, Zhangfei/
CREBZF/SMILE inhibits the growth and the unfolded
protein response (UPR) in the D–17 canine osteosarcoma
(OS) cell line [5] and that the effects of Zhangfei are* Correspondence: vikram.misra@usask.ca
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unless otherwise stated.mediated by stabilizing the tumour suppressor protein
p53 [6]. To determine if our observations with D–17 cells
applied more universally to canine OS, we examined three
other independently isolated canine OS cell lines—Abrams,
McKinley [7-10] and Gracie [11]. The purpose of this study
was to determine the inhibitory role of Zhangfei in these
OS cell lines by exploring its potential involvement in
growth, differentiation, apoptosis, and metastasis.
Zhangfei was initially identified through its inter-
action with the host cell factor (HCF1) a protein re-
quired for the initiation of herpes simplex virus gene
expression [12]. Unlike other bLZip transcription fac-
tors, Zhangfei appears to be incapable of binding to
consensus bLZip response elements as a homodimer
[13]. Instead, it fulfills its role in transcriptional regula-
tion by hetero-dimerizing with and modulating other
transcription factors or signaling molecules, such asThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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[17], herpes simplex virus VP16 [18], and p53 [19].
Results and discussion
All four canine OS cells lines express functional p53
To confirm the effects of Zhangfei we had observed in
D–17 OS cells we examined three other canine OS cell
lines. We have shown that Zhangfei exerts its effect on
cell growth and the UPR by stabilizing p53 [6] and it
therefore has no effect on cancer cells that do not pos-
sess functional p53. To assess the status of p53 in the
canine cell lines we amplified p53 transcripts from the
cells using PCR and determined the nucleotide se-
quences of the products. Figure 1B shows the derived
amino acid sequences of p53 from the cell lines and the
reference sequence from the canine genome database.
All four cell lines contained transcripts for p53 that, with
the exception of a few amino acid variations, were iden-
tical to the reference sequence. None of the amino acid
polymorphisms in the sequences were at positions iden-
tified as important for p53 function [20] (Figure 1A,B).
To determine if the p53 proteins in the cell lines were
functionally active, we transfected the cells with a plas-
mid that expressed the reporter protein chloramphenicol
acetyl transferase (CAT) regulated by a promoter with
two copies of a p53 response element (pCATp53RE). As
a negative control, cells were transfected with a plasmid
(pCAT3B) without the response elements. Parallel cul-
tures were transfected with a plasmid expressing Zhangfei.
Figure 1C shows that expression of CAT was activated in
all four cell lines in a p53 response element–dependent
manner and that the presence of Zhangfei enhanced
expression.
Cellular outcome following ectopic expression of
Zhangfei: growth arrest, apoptosis and differentiation
We next compared the effect of Zhangfei on the growth
characteristics of Abrams, McKinley, and Gracie cells
with its effect on D–17 cells. The cells were infected
with adenovirus expressing either Zhangfei (Adeno-ZF)
or the control protein β-galactosidase (Adeno-LacZ).
Cell growth was monitored by the WST-1 Cell Prolifera-
tion Assay. In agreement with previous results, all four
Adeno-ZF-infected cells failed to divide as early as day 1
after infection as determined by their ability to convert
WST-1 Cell Proliferation reagent and absorb light at
405 nm. Mock infected cells continued to grow for three
days and the growth of Adeno-LacZ-infected cells was
indistinguishable from mock-infected cells (Figure 2).
Apoptosis was induced in all four cell lines as a result of
Zhangfei expression (Figure 3). D–17 and Abrams ap-
peared to be more sensitive as cultures had substantial
numbers of apoptotic cells at 24 hr. The response in
McKinley and Gracie, was slower with cultures showing20 to 34% apoptotic cells by 48 hr. Since the level of p53
in response to Zhangfei was similar in all the cell lines
the quantitative differences in the induction of apoptosis
suggests that Zhangfei may have effects that are, at least
partially, independent of p53.
Since the effect of Zhangfei was most dramatic on D–17
and Abrams cells we selected them for further analysis.
Zhangfei may stop cell growth by inducing differentiation
and/or causing apoptosis, we therefore performed a tran-
script level analysis of the OS differentiation marker—
osteocalcin [21] in D–17 and Abrams cells infected
with either Adeno-ZF or Adeno-LacZ. Compared with
LacZ-expressing and even vitamin D3-treated cells
(negative and positive controls, respectively), Zhangfei
significantly increased the expression of osteocalcin
transcripts in a time-dependent manner (Figure 4).
Expression of Zhangfei inhibits the ability of canine
osteosarcoma cells to close a scratch wound
Migratory behaviour in cancer cells is a typical hallmark
of malignancy. To investigate whether ectopic expres-
sion of Zhangfei correlated with altered migratory be-
haviour, we performed cell motility assays on the canine
OS cultures. Following scratch wounding, wound closure
was significantly slower in cultures (D–17 and Abrams
canine cells) infected with Adeno-ZF compared to cul-
tures infected with Adeno-LacZ or mock-infected cells
(Figure 5), showing that the ectopic expression of
Zhangfei indeed causes decreased cell motility in canine
osteosarcoma cells. However, it is also possible that the
decrease in ability of Zhangfei-expressing cells to grow
heal the scratch wound may be because of a decrease in
growth rates rather than a decrease in the ability to
migrate.
Zhangfei negatively regulates the UPR in canine
osteosarcomas
The unfolded protein response (UPR) is an adaptive cel-
lular stress response that alleviates ER stress or, failing, in-
duces apoptosis. In previous studies, we found Zhangfei
was a negative regulator of the UPR in D–17 canine OS
cells [5]. To investigate if Zhangfei could consistently sup-
press the UPR in other canine OS cells, the four canine
OS cell lines infected with either Adeno-ZF or Adeno-LacZ
were treated with the UPR pharmacological inducer thap-
sigargin, or were deprived of glucose. The latter treatment
is a known physiological inducer of the UPR. Both treat-
ments increased the level of transcripts for UPR tran-
scripts Xbp1s, HERP, CHOP and GRP78 (Figure 6A) and
Zhangfei suppressed the transcripts in thapsigargin treated
(Figure 6B) and glucose deprived (Figure 6C) cells. In con-
trast, LacZ had no obvious effect. In addition, this decrease
in mRNA was reflected in a decrease in UPR proteins
(Xbp1s, HERP, and GRP78) in thapsigargin-treated D–17
Figure 1 (See legend on next page.)
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Figure 1 p53 in dog osteosarcoma cell lines. (A) Schematic structure of full-length p53. TAD: N-terminal transactivation domain; PRR: proline-rich
region; p53C: central DNA-binding domain; TET: tetramerization domain; CT: extreme carboxyl terminus. p53C is the domain where most cancer-
associated p53 mutations are located. The numbers below the diagram indicate amino acid residues delineating the domains and numbers above the
diagram represent the residues with highest frequency of oncogenic missense mutations [20]. (B) Derived amino acid sequence alignment of p53s
from 4 dog OS cell lines and dog wild-type p53. The residues that have high mutant frequency were marked above the diagram. Accession numbers:
KP279761, KP279762, KP279763, KP279764 (C) p53 proteins of dog OS cell lines have transcriptional activity, and Zhangfei enhances p53-dependent
transactivation. D–17, Abrams, McKinley, and Gracie cells were transfected with 0.5 μg of pCAT3B or pCAT3B-p53RE, in the presence or absence of 1 μg
of pcZF. 24 h after transfection, the CAT activity was determined. Values represented the relative CAT activity (adjusted by β-galactosidase) of different
treatments. Standard deviations from means of three individual experiments are shown. Significance of differences of the means (*P < 0.05, **P < 0.01)
were determined using ANOVA.
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intracellular proteins detected by immunofluorescence,
also supported these data—the Xbp1s protein was un-
detectable in D–17 and Abrams cells expressing Zhangfei.
Conclusions
Canine OS is an aggressive tumour that accounts for ap-
proximately 85% of primary bone tumours in the dog
[22]. OS causes local skeletal destruction resulting in
osteoproductive and osteolytic lesions, and it is highly
metastatic to the lungs. Although there has been dra-






















































Figure 2 Ectopic expression of Zhangfei suppresses cell growth in ca
cells were mock-infected or infected with adenovirus vectors expressing ei
rates were measured (A) by absorbance at 405 nm with WST-1 at different
means of three individual experiments. Standard deviations from means of
**P < 0.01) was determined using ANOVA. (B). Zhangfei was detected by imincluding amputation, chemotherapy, and palliative radi-
ation therapy, these therapies often fail, leading to recur-
rence of the tumour and metastatic spread [23-26]. Over
the years, combined therapies, such as chemotherapy
combined with immune modulators, have been practiced
on dog OS [27,28], although with poor overall survival
times.
The dog is a well-established model for spontaneous
OS in humans, owing to striking similarity in biology
and gene expression. The large size of dogs, relative out-
breeding, and immunocompetence increase their model



















































nine osteosarcomas. D–17, Abrams, McKinley, and Gracie canine OS
ther Zhangfei (Adeno-ZF) or β-galactosidase (Adeno-LacZ) and growth
time points after infection. Error bars indicate standard deviations from
three individual experiments are shown and significance (*P < 0.05,
munoblotting using antiserum against Zhangfei.
















































Figure 3 Zhangfei causes canine osteosarcoma cells to commit apoptosis. D–17, Abrams, McKinley and Gracie cells, mock-infected or
infected with Adeno-ZF or Adeno-LacZ or treated with 50 μM etoposide (positive control) were stained with fluorescent Annexin V and propidium
iodide. Unstained cells or cells staining with either or both dyes were enumerated by FACS. A4 represents the percentage of total cells undergoing
apoptosis. For McKinley and Gracie only reading for 48 hr are shown. Differences between LacZ and ZF-expressing cells were more pronounced at
that time-point.



























































Osteocalcin in Abrams cells
Figure 4 Zhangfei induces differentiation of canine osteosarcoma cells. D–17 and Abrams cells were either mock-infected or infected with
Adeno-ZF or Adeno-LacZ. The positive control cells were treated with 10-5 mM vitamin D3. The mRNA levels of osteoblast differentiation marker
(osteocalcin) were estimated by qRT-PCR. Standard deviations from means and P values as calculated using a Student T-test are shown.
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addition, tumor burdens in spontaneously arising can-
cers of dogs are more similar to humans than the expe-
rimentally induced tumors found in murine models,
which may be important with regard to biologic factors
such as hypoxia and clonal variation. The size of canine
tumors also allows for serial imaging and tissue collec-
tion over time [29].
In previous studies, we found that the transcription
factor CREBZF/Zhangfei suppressed the growth of D–17
dog OS cells [5]. Herein, we further discovered that the
growth suppressive effects of Zhangfei were applicable
to three other independently isolated canine OS cell
lines as well.
The unfolded protein response (UPR) is an adaptive re-
sponse induced by endoplasmic reticulum (ER) stress,
which alleviates ER stress by up-regulating the expression
of ER-resident chaperons [30], inducing ER-associated
protein degradation (ERAD), and down-regulating the
synthesis of new proteins [31,32]. If these mechanisms are
not sufficient to alleviate ER stress, then an apoptosis pro-
gram is initiated to induce cell death. Our previous results
[15] suggest that Zhangfei is a potential regulator of the
UPR, and it might accelerate UPR feedback mechanismsby interacting with the UPR mediator-Xbp1 and target-
ing it for proteasomal degradation. In the present
study, the strong inhibitory effects of Zhangfei on both
pharmacological (thapsigargin) and physiological (glu-
cose deprivation) –induced UPR was also observed in
the four canine OS cell lines we examined.
Zhangfei suppresses the UPR and cell growth by sta-
bilizing the tumour suppressor protein p53 [6]. All four
canine OS cell lines we examined express functional p53
(Figure 1). These results suggest that the induction of
Zhangfei expression in canine OS may be an effective
strategy for suppressing cell growth and metastasis.
However, the strategy would likely only be successful
with OS that have functional p53. A large proportion of
human cancers have deleted or otherwise non-functional
p53. At present we do not know the proportion of ca-
nine OS that have inactive p53. Some studies [33] sug-
gest that most canine OS do not have deletions or major
rearrangements in the gene for p53. Although 30–50% of
p53 coding sequences in canine OS have polymorphisms
[33-35] the effect of these changes on p53 functionality is
unknown. It is therefore difficult to determine how univer-
sally applicable Zhangfei would be as a modality for treat-





























































Figure 5 Ectopic expression of Zhangfei causes decreased ability of canine osteosarcoma cells to repair a scratch wound. (A) Scratch
wounds were made in 100% confluent cultures of D–17 or Abrams cells mock-infected or infected with Adeno-ZF or Adeno-LacZ. Phase contrast
images were taken at 0, 4, 8, 12, and 24 hours after infection from identical regions. (B) The wound size relative to the starting wound size was
measured at each time point after infection in three independent experiments and expressed as a percentage reduction in wound size + standard
deviation. Significance of differences of means (*P < 0.05, **P < 0.01) were determined using ANOVA.
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cells, both in vitro and in vivo models leads to reduced
tumour growth and an increase in apoptotic cells
[5,36,37]. In contrast, other studies in both humans [38]
and dogs [39,40] suggest that increased p53 expression in
OS correlates with more aggressive tumours and decreases
survival time.
Methods
Cells and tissue culture
Canine osteosarcoma D–17 cells, obtained from the
American Type Tissue Culture Collection, were grown
in MEM-Alpha containing 10% fetal bovine serum
(FBS). Canine Abrams, McKinley and Gracie cell lines
were grown in Dulbecco’s minimal essential medium
containing penicillin, streptomycin and 10% newborn
calf serum. All media, serum and antibiotics were pur-
chased from Invitrogen (Carlsbad, California). Abrams
cells were derived from metastatic OS nodules whereas
McKinley and Gracie cells were from primary tumours.
All cell lines were confirmed to be of canine origin by
multispecies multiplex PCR and identified by short tan-
dem repeat analysis as described [41].Adenovirus Vectors Expressing Zhangfei and
ß-galactosidase (LacZ)
These vectors were constructed, grown, and purified using
the Adeno-X Expression System (Clontech). They were
created in our laboratory as described earlier [14]. Cells
were infected with Adeno-Zhangfei, Adeno-LacZ (ex-
pressing E. coli ß-galactosidase, LacZ) or mock-infected. A
multiplicity of infection (MOI) of 100 plaque-forming
units (pfu) per cell was used.
WST-1 cell proliferation and viability assay
To determine the growth rate of cells, 104 cells/well were
seeded into 96-well plates. 24 h later cells were either
mock infected or infected with adenovirus vectors express-
ing Zhangfei (Adeno-ZF) or ß-galactosidase (Adeno-LacZ).
Cell proliferation was assessed using Cell Proliferation Re-
agent WST-1 (Roche, Mannheim, Germany) according to
the manufacturer’s specifications.
Annexin V-apoptosis assay
Cells were collected after trypsinization and stained with
Annexin V and propidium iodide (PI) using an Annexin V
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Figure 6 Zhangfei negatively regulates the Unfolded Protein Responses (UPR) in canine osteosarcomas. (A) D–17 cells were left untreated,
treated with thapsigargin or grown in glucose free medium. Twelve hours later cells were harvested and transcripts for the UPR- linked genes Xbp1s,
HERP, CHOP and GRP78 estimated by qRT-PCR. Cells were mock-infected or infected with either Adeno-ZF or Adeno-LacZ and then treated with
thapsigargin (B) or deprived of glucose (C). 24 hr later cells were harvested and transcripts for UPR genes estimated. Proteins in thapsigargin-treated
mock-infected and Adeno-ZF-infected cells were detected by immunoblots (D) and immunofluorescence (E). Dotted lines in A and B indicate a 2-fold
difference. Values greater than 2 fold were considered significant.
Zhang et al. BMC Veterinary Research  (2015) 11:22 Page 8 of 11a positive control cells were treated with 50 μM etopocide
(Calbiochem) for 24 hr. Cells were analyzed in a Coulter
EPICS XL flow cytometer. In this assay, early apoptotic
cells stained with Annexin V but not with PI while late
apoptotic or necrotic cells stained with both Annexin V
and PI.Scratch wound healing assay
Scratch wounds more than 5 mm in length and of equal
thickness were made in 100% confluent cultures of D–17
or Abrams cells mock-infected or infected with Adeno-ZF
or Adeno-LacZ with a 10 μL disposable micropipette tip.
Phase contrast images were obtained at 0, 4, 8, 12, and
Zhang et al. BMC Veterinary Research  (2015) 11:22 Page 9 of 1124 hours after infection from identical regions. The wound
size at each time point after infection relative to the start-
ing wound size was measured using Photoshop software
in three independent experiments.
Quantitative real-time PCR (qPCR)
Total RNA was extracted using RNeasy Plus Mini Kit
from Qiagen (Mississauga, ON, Canada). Gene expres-
sion was analyzed by RT-PCR using Brilliant II SYBR
Green QPCR Master Mix Kit (Agilent Technologies).
Levels of GAPDH were used to normalize the samples.
All reactions were analyzed in duplicate and each experi-
ment was repeated at least twice. Relative fold changes
of transcript levels were calculated as 2ΔΔ Ct. Nucleotide
sequences of the primers used are in Table 1. The iden-
tity of all products was confirmed by electrophoretic
mobility on mobility on agarose gels and by determining
nucleotide sequence. Only results with homogeneous
thermal disassociation profiles were considered.
PCR and sequencing of p53 genes
The sequences of PCR primers used for canine p53
amplification were: canine p53-forward: GGTGACTG
CAATGGAGGAGTCGCA, canine p53-reverse: TCAGT
CTGAGTCAAGCCCTTCTCT. RNA was purified from
cells using the RNEasy Plus mini kit with a genomic
DNA elimination step (Qiagen) and RNA converted to
cDNA with the Quantitect Reverse Transcription kit
(Qiagen) using instructions supplied by the manufac-
turer. Two-step RT-PCR reactions used TopTaq emzyme
(Qiagen) and were performed in a PCR machine. Se-
quences were aligned using the software, MacVector.
Nucleotide sequences for coding sequences for p53
transcripts recovered from D17, Abrams, McKinley and
Gracie cell lines were submitted to GenBank/NCBI
and were assigned the following accession numbers:













All sequences are in the 5′–3′ direction.Plasmids and chloramphenicol acetyl transferase (CAT) assay
The construction of pcZF [12], a plasmid that expresses
Zhangfei in mammalian cells, has been described. The
CAT reporter plasmid pCAT3B-p53RE was constructed
by transferring oligonucleotides containing two copies of
p53 responsive element, GGTCAAGTTGGGACACGTC
CaaGAGCTAAGTCCTGACATGTCT (IDT, Coralville,
Iowa), to pCAT3Basic (Promega), which contains the
coding sequence for CAT linked to a basal promoter.
Oligonucleotides representing the p53 responsive ele-
ments with overhanging 5′ terminal KpnI and 3′ terminal
BglII sites were annealed and ligated to pCAT3Basic cut
with the same enzymes.
In CAT assay, D–17, Abrams, Gracie and McKinley cells
were transfected with 0.5 μg of pCAT3B-p53RE, in the
presence or absence of a plasmid expressing Zhangfei
(pcZF, 1 μg), using Lipofectamine 2000 (Invitrogen) as de-
scribed in the manufacturer’s instructions. The promoter-
less parental reporter plasmid, pCAT3B was included as a
control to show basal CAT activity. 250 ng of pCMVBGal,
a plasmid specifying β-galactosidase, were added to each
transfection as an internal control. 24 h after transfection,
the CAT activity was determined by ELISA. CAT values
were normalized to β-galactosidase.
Antibodies, immunoblotting and immunofluorescence
The antibodies used were mouse anti-FLAG (Sigma),
rabbit anti-Zhangfei serum [12], rabbit anti-Xbp1 (Abcam,
Cambridge, MA), rabbit anti-HERP (Abcam, Cambridge,
MA), rabbit anti-GRP78 (Abcam, Cambridge, MA), and
mouse anti-GAPDH (Chemicon, Billerica, MA). Suppliers
of antibodies against Xbp1, HERP, GRP78 and GAPDH
indicated that they recognized canine proteins. Secondary
antibodies were goat anti-mouse Alexa488, goat anti-
rabbit Alexa546 and goat anti-rabbit Cy5 (Invitrogen).
Cells were processed for immunoblotting and immuno-
fluorescence as described previously [5,12].
Statistical analysis
Statistical analysis of data was performed by Student T-test
or ANOVA using IBM SPSS statistics version 21.0.0 soft-
ware. ANOVA tests with LSDpost hoc comparison was
used to analyze the differences between multi-group
means and their associated procedures by adding individ-
uals as a treatment variable, and a paired T-test was used
to evaluate the effects of one treatment compared with no
treatment/control. A P value of less than 0.05 was consid-
ered to be statistically significant for both tests.
Availability of supporting data
Accession numbers sequences supporting the results of this
article are available in the GenBank repository, [GenBank:
KP279761, GenBank:KP279762, GenBank:KP279763,
GenBank:KP279764].”
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